Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,580.00    0.00 (0.00%)
Bid:
4,150.00
Ask:
4,650.00
Spread: 500.00 (12.048%)
Market Cap: £98.63b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

UNILEVER COMPLETES SHARE BUYBACK PROGRAMME

30 Nov 2018 16:56

RNS Number : 1252J
Unilever PLC
30 November 2018
 

UNILEVER COMPLETES SHARE BUYBACK PROGRAMME

 

London/Rotterdam, November 30, 2018 - Unilever PLC and Unilever N.V. today announce the successful completion of the second tranche of the programme to buy shares with an aggregate market value equivalent of €3 billion (the 'Second Tranche'). Between 20 July and 30 November 2018, 30,576,447 Unilever N.V. shares and 31,458,088 Unilever PLC shares were purchased.

 

With the completion of the Second Tranche Unilever has delivered on its intention, as announced on 19 April 2018, to buy back shares with an aggregate market value equivalent of up to €6 billion, in line with Unilever's objective to return the after-tax proceeds of the Spreads disposal to shareholders.

 

 

Unilever contacts

For more information, please contact:

 

Lucila Zambrano

+ 44 7825273767

Lucila.Zambrano@unilever.com

Fleur Van-Bruggen

+31 615 008 293

Fleur-van.bruggen@unilever.com

 

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

 

 

*********************************************************************************************

 

Cautionary Statement regarding Forward-Looking Statements

This announcement may contain forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, including statements related to underlying sales growth and underlying operating margin. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends' or 'intention', 'looks', believes', 'vision', 'considers' or the negative of these terms and other similar expressions and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group ("Unilever" or the "Unilever Group"). They are not historical facts, nor are they guarantees of future performance.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; inability to find sustainable solutions to support long-term growth; customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain; the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; successful execution of acquisitions, divestitures and business transformation projects; economic and political risks and natural disasters; the effect of climate change on Unilever's business; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Unilever Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Unilever Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Further details of potential risks and uncertainties affecting the Unilever Group are described in the Unilever Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2017 and the Unilever Annual Report and Accounts 2017.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSLLFERLVLIVIT
Date   Source Headline
23rd Jul 20207:00 amRNSHalf-year Report
22nd Jul 20202:42 pmRNSNotice of Separate Adjourned Meetings
22nd Jul 20202:32 pmRNSUnilever Announces Results of Bondholder Meetings
13th Jul 20209:00 amRNSExtension of Early Instruction Deadline
9th Jul 202012:34 pmRNSDirector/PDMR Shareholding
26th Jun 20201:30 pmRNSDIP – Notice of Separate Meetings
26th Jun 20201:15 pmRNSConsent Solicitations
11th Jun 20207:00 amRNSUnification of Unilever’s legal structure
9th Jun 20201:47 pmRNSDirector/PDMR Shareholding
5th Jun 202011:29 amRNSDirector/PDMR Shareholding
12th May 20201:22 pmRNSDirector/PDMR Shareholding
30th Apr 202011:45 amRNSMembership of Board Committees
29th Apr 20204:56 pmRNSDirector/PDMR Shareholding
29th Apr 20203:52 pmRNSResult of AGM
27th Apr 20206:00 pmRNSListing Rule 9.2.6E statement
23rd Apr 20207:00 amRNS1st Quarter 2020 Trading Statement
20th Apr 20205:20 pmRNSUnilever Annual General Meetings update
9th Apr 202011:44 amRNSDirector/PDMR Shareholding
1st Apr 20201:15 pmRNSCompletion of Horlicks acquisition from GSK
30th Mar 202012:30 pmRNSDirector/PDMR Shareholding
24th Mar 20204:43 pmRNSSecond Price Monitoring Extn
24th Mar 20204:37 pmRNSPrice Monitoring Extension
24th Mar 202012:00 pmRNSPublication of Final Terms
24th Mar 202011:00 amRNSHelping to protect lives and livelihoods: Covid-19
23rd Mar 20206:13 pmRNSDirector/PDMR Shareholding
23rd Mar 202012:08 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:03 pmRNSPrice Monitoring Extension
19th Mar 20202:59 pmRNSDirector/PDMR Shareholding
19th Mar 202010:45 amRNSNotice of AGM update
19th Mar 202010:20 amRNSNotice of AGM
13th Mar 20203:45 pmRNSPublication of Suppl.Prospcts
10th Mar 202011:24 amRNSDirector/PDMR Shareholding
10th Mar 20207:30 amRNSAnnual Financial Report
4th Mar 20202:30 pmRNSBoard Composition Announcement
20th Feb 20203:09 pmRNSDirector/PDMR Shareholding
18th Feb 20204:10 pmRNSDirector/PDMR Shareholding
11th Feb 20201:51 pmRNSDirector/PDMR Shareholding
5th Feb 202010:42 amRNSDirector/PDMR Shareholding
30th Jan 20207:00 amRNSFinal Results
10th Jan 202012:08 pmRNSDirector/PDMR Shareholding
17th Dec 20197:00 amRNSUnilever Sales Update
11th Dec 20193:06 pmRNSDirector/PDMR Shareholding
9th Dec 20195:10 pmRNSDirector/PDMR Shareholding
5th Dec 201912:47 pmRNSDirector/PDMR Shareholding
13th Nov 20197:00 amRNSUnilever Chairman announcement
11th Nov 20193:02 pmRNSDirector/PDMR Shareholding
17th Oct 20197:00 amRNS3rd Quarter Trading Statement
10th Oct 20199:17 amRNSDirector/PDMR Shareholding
18th Sep 20192:00 pmRNSTreatment of hyperinflationary countries
16th Sep 20195:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.